About Acadia Pharmaceuticals Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer’s disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs. At Acadia, we’re here to be their difference. Please note that this position can be based in Princeton, NJ or San Diego, CA. Acadia's hybrid model requires this role to work in our office three days per week on average. Position Summary: The Director, External Innovation will lead the scientific assessment and evaluation of new asset and partnership opportunities aligned with the company’s corporate strategy and R&D portfolio across Neuroscience, Psychiatry, Neuro-rare, and Non-neuro Rare Disease areas. In this role, you’ll be at the forefront of identifying promising science and helping determine which opportunities have the potential to strengthen the pipeline and create meaningful impact for patients. This role plays a key part in identifying, evaluating, and advancing global in-licensing, acquisition, and partnership opportunities. You’ll collaborate closely with cross-functional leaders to support diligence, inform strategic decision-making, and contribute to transaction execution, while building trusted relationships across the biotech, pharmaceutical, and academic communities.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior